RIPK1 Knockout HEK293T Cell Line

The choice depends on whether you are studying RIPK1's role as a central regulator of TNF receptor signaling, NF-κB activation, apoptosis, and necroptosis or its scaffolding function in the TNFR1 signaling complex. The Knockout line is the standard tool for asking whether RIPK1 is required for these processes — RIPK1 is the principal upstream regulator of necroptosis through RIPK3 recruitment and is essential for many cytokine-induced inflammatory and cell death responses. Overexpression is useful for studying RIPK1's gain-of-function effects or for testing necroptosis pathway components. For cell death and inflammation research, the EDITGENE RIPK1 Knockout in HEK293T is a high-value mechanistic platform — HEK293T's very high transfection efficiency supports systematic structure-function studies of this complex multi-domain kinase. Rescue with wild-type, kinase-dead (K45A), or RHIM-mutant RIPK1 enables comprehensive dissection of kinase activity, scaffolding, and necroptosis-specific functions. The knockout serves as a critical specificity control for RIPK1 kinase inhibitors (necrostatin-1, GSK2982772, DNL747/SAR443060) in clinical development for inflammatory and neurodegenerative diseases.

Primary applications: • TNF signaling: NF-κB activation, apoptosis (caspase-8 cleavage), and necroptosis (phospho-MLKL) following TNF-α stimulation in the absence of RIPK1. • Necroptosis pathway studies: TNF + zVAD + Smac mimetic-induced necroptosis with phospho-RIPK3 (S227) and phospho-MLKL (S358) readouts. • Inflammatory signaling: response to LPS, TLR3 ligands, and ZBP1-activating stimuli to characterize RIPK1's roles in different inflammatory contexts. • RIPK1 inhibitor specificity: critical genetic control for necrostatin-1, GSK2982772, DNL747/SAR443060, and other RIPK1 kinase inhibitors in clinical development. EDITGENE recommends this model for researchers investigating cell death biology, inflammatory signaling, necroptosis mechanisms, and RIPK1-targeted therapeutic development.

Yes. RIPK1 rescue experiments are well-established for cell death pathway research: • Construct design: use a codon-modified RIPK1 sequence with a small C-terminal tag (FLAG, HA). RIPK1 has N-terminal kinase domain, central intermediate domain (RHIM-containing), and C-terminal death domain — preserve all elements. • Kinase-dead rescue: the K45A mutation abolishes catalytic activity and is the standard control for distinguishing kinase from scaffolding functions — particularly critical because necroptosis requires RIPK1 kinase activity while NF-κB activation does not. • RHIM-mutant rescue: tetraAla mutations in the RIP homotypic interaction motif (RHIM) disrupt RIPK3 interaction and abolish necroptosis without affecting NF-κB or apoptosis functions. • Functional readout: rescue should restore TNF-induced NF-κB activation, apoptosis sensitivity, and necroptosis (phospho-MLKL) responses. HEK293T transduces with very high efficiency and supports systematic RIPK1 rescue experiments.